8 Galectin-3 correlates with arrhythmogenic right ventricular cardiomyopathy and predicts the risk of ventricular -arrhythmias in patients with implantable defibrillators.

9 Distinguishing Right Ventricular Cardiomyopathy From Idiopathic Right Ventricular Outflow Tract Tachycardia with T-wave Alternans.

10 Novel Oral Anticoagulants for Primary Stroke Prevention in Hypertrophic Cardiomyopathy Patients With Atrial Fibrillation.

11 Prevalence and characteristics of dysfunction of right ventricle in peripartum cardiomyopathy

12 Peripartum cardiomyopathy: challenges and solutions

13 Takotsubo cardiomyopathy: etiology, diagnosis, and optimal management

14 Possible space flight-induced catecholamine cardiomyopathy: Neil Armstrong's last 20 lunar minutes

15 Prevalence and characteristics of dysfunction of right ventricle in peripartum cardiomyopathy

16 Peripartum cardiomyopathy: challenges and solutions

17 Takotsubo cardiomyopathy: etiology, diagnosis, and optimal management

18 Possible space flight-induced catecholamine cardiomyopathy: Neil Armstrong's last 20 lunar minutes

19 Hypertrophic cardiomyopathy genetic test reports: A qualitative study of patient understanding of uninformative genetic test results.

20 Reevaluation of genetic variants previously associated with arrhythmogenic right ventricular cardiomyopathy integrating population-based cohorts and proteomics data.

21 Diabetic cardiomyopathy: acute and reversible left ventricular systolic dysfunction due to cardiotoxicity of hyperglycaemic hyperosmolar state-a case report†.

22 Performance of Prognostic Heart Failure Models in Patients With Nonischemic Cardiomyopathy Undergoing Ventricular Tachycardia Ablation.

23 Effects of candesartan on electrical remodeling in the hearts of inherited dilated cardiomyopathy model mice.

24 The Role of Cardiac MRI in the Management of Ventricular Arrhythmias in Ischaemic and Non-ischaemic Dilated Cardiomyopathy.

25 Calcitriol and Punica Granatum Extract Concomitantly Attenuate Cardiomyopathy of Diabetic Mother Rats and Their Neonates via Activation of Raf/MEK/ERK Signalling and Mitigation of Apoptotic Pathways.

26 The effectiveness of cardiac rehabilitation in non-ischemic dilated cardiomyopathy patients: A pilot study.

27 Importance of Genetic Testing in Dilated Cardiomyopathy: Applications and Challenges in Clinical Practice.

28 CaMKII-δ9 promotes cardiomyopathy through disrupting UBE2T-dependent DNA repair.

29 Cardiomiopatia isquêmica terminal associada à complicação do uso de stent no tratamento de infarto agudo do miocárdio Terminal ischemic cardiomyopathy associated with complication of stenting in the treatment of acute myocardial infarction

30 Mortality and respiratory support in X-linked myotubular myopathy: a RECENSUS retrospective analysis.

31 Centronuclear myopathy in Labrador retrievers: a recent founder mutation in the PTPLA gene has rapidly disseminated worldwide.

32 Ecstasy induced acute systolic heart failure and Non-Ischemic Cardiomyopathy in a young female: a rare case report and literature review.

33 Native T1 time and extracellular volume fraction in differentiation of normal myocardium from non-ischemic dilated and hypertrophic cardiomyopathy myocardium: A systematic review and meta-analysis.

34 Thyroid Storm-induced Severe Dilated Cardiomyopathy and Ventricular Tachycardia.

35 Dilated cardiomyopathy as a rare presentation of the pulmonary sequestration: A case report with aberrant vessel from aorta to left lower pulmonary lobe.

36 Metabolic reprogramming orchestrates CD4 T-cell immunological status and restores cardiac dysfunction in autoimmune induced-dilated cardiomyopathy mice.

37 The circulating level of interleukins 6 and 18 in ischemic and idiopathic dilated cardiomyopathy.

38 Decreased eGFR Is Associated With Ischemic Stroke in Patients With Dilated Cardiomyopathy.

39 Increased mortality and ICD therapies in ischemic versus non-ischemic dilated cardiomyopathy patients with cardiac resynchronization having survived until first device replacement.

40 Association between right ventricular two-dimensional strain and exercise capacity in patients with either idiopathic or ischemic dilated cardiomyopathy

41 Melatonin attenuates ER stress and mitochondrial damage in septic cardiomyopathy: A new mechanism involving BAP31 upregulation and MAPK-ERK pathway.

42 Metabolic Profiling Associates with Disease Severity in Non-Ischemic Dilated Cardiomyopathy.

43 Left ventricular ejection hemodynamics before and after relief of outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy and valvular aortic stenosis.

44 Myocardial adaptation after surgical therapy differs for aortic valve stenosis and hypertrophic obstructive cardiomyopathy.

45 Myocardial work is a predictor of exercise tolerance in patients with dilated cardiomyopathy and left ventricular dyssynchrony.

46 Sex Differences in the Long-term Prognosis of Dilated Cardiomyopathy.

47 Incidence and Natural History of Left Bundle Branch Block Induced Cardiomyopathy.

48 Tachycardia-induced cardiomyopathy in a patient with left-sided accessory pathway and left bundle branch block: A case report

49 Peri-left bundle branch pacing in a patient with right ventricular pacing-induced cardiomyopathy and atrioventricular infra-Hisian block

50 Sex-specific clinical outcomes after cardiac resynchronization therapy in left bundle branch block-associated idiopathic nonischemic cardiomyopathy: A NEOLITH II substudy

51 Early Use of Cardiac Resynchronization Therapy to Accelerate Symptomatic Relief and Complete Left Ventricular Function Recovery in Peripartum Cardiomyopathy

52 Left Ventricular Noncompaction Syndrome: A Rare Congenital Cardiomyopathy

53 Synthesis of Isosteviol analogues as potential protective agents against Doxorubicin-induced cardiomyopathy in zebrafish embryos

54 Extracorporeal shock waves protect cardiomyocytes from doxorubicin-induced cardiomyopathy by upregulating survivin via the integrin-ILK-Akt-Sp1/p53 axis

55 Blockade of L-type Ca<sup>2+</sup> channel attenuates doxorubicin-induced cardiomyopathy via suppression of CaMKII-NF-κB pathway

56 Expression and localization of P-glycoprotein in human heart: effects of cardiomyopathy.

57 Takotsubo cardiomyopathy secondary to haemophagocytic lymphohistiocytosis in HIV patients: a comprehensive review.

58 Emetine-induced cardiomyopathy in rabbits -c Yusuf Khan M. Haider B. Thind I.S.

59 Isosteviol ameliorates diabetic cardiomyopathy in rats by inhibiting ERK and NF-κB signaling pathways

60 [Treatment strategies of patients with transthyretin amyloidosis cardiomyopathy].

61 Echocardiographic parameters, speckle tracking, and brain natriuretic peptide levels as indicators of progression of indeterminate stage to Chagas Cardiomyopathy.

62 Associations among echocardiography, cardiac biomarkers, insulin metabolism, morphology, and inflammation in cats with asymptomatic hypertrophic cardiomyopathy.

63 A novel marker of persistent left ventricular systolic dysfunction in patients with peripartum cardiomyopathy: monocyte count- to- HDL cholesterol ratio.

64 Recurrence of cardiomyopathy by recurrent pheochromocytoma.

65 Myositis with sarcoplasmic inclusions in Nakajo-Nishimura syndrome: a genetic inflammatory myopathy.

66 Dysregulation of Calcium Handling in Duchenne Muscular Dystrophy-Associated Dilated Cardiomyopathy: Mechanisms and Experimental Therapeutic Strategies.

67 Pigs with δ-sarcoglycan deficiency exhibit traits of genetic cardiomyopathy.

68 Stabilization of the cardiac sarcolemma by sarcospan rescues DMD-associated cardiomyopathy

69 Therapeutic approaches to diabetic cardiomyopathy: Targeting the antioxidant pathway.

70 The altered expression of autophagy-related genes participates in heart failure: NRBP2 and CALCOCO2 are associated with left ventricular dysfunction parameters in human dilated cardiomyopathy.

71 Myocardium of patients with dilated cardiomyopathy presents altered expression of genes involved in thyroid hormone biosynthesis.

72 Cytoskeletal derangements in hereditary myopathy with a desmin L345P mutation

73 Left Ventricular Geometry and Replacement Fibrosis Detected by cMRI Are Associated with Major Adverse Cardiovascular Events in Nonischemic Dilated Cardiomyopathy

74 Smart Supervision of Cardiomyopathy Based on Fuzzy Harris Hawks Optimizer and Wearable Sensing Data Optimization: A New Model

75 Intra-axonal polysaccharide deposits in the peripheral nerve seen in adult polysaccharide storage myopathy

76 Modifications of Titin Contribute to the Progression of Cardiomyopathy and Represent a Therapeutic Target for Treatment of Heart Failure

77 Dominantly inherited myopathy with novel tubular aggregates containing 1–21 tubulofilamentous structures

78 Abundant minute myotubes in a patient who later developed centronuclear myopathy

79 Valosin-containing protein and the pathogenesis of frontotemporal dementia associated with inclusion body myopathy

80 Immunohistochemical study of clathrin in distal myopathy with rimmed vacuoles

81 takotsubo cardiomyopathy after spinal anesthesia for a minimally invasive urologic procedure

82 uremic cardiomyopathy: a new piece in the chronic kidney disease-mineral and bone disorder puzzle

83 ventricular arrhythmogenic potential assessment in an asymptomatic ischemic cardiomyopathy patient with a normal ejection fraction

84 kansas city cardiomyopathy questionnaire utility in prediction of 30-day readmission rate in patients with chronic heart failure

85 cyclovirobuxine d attenuates doxorubicin-induced cardiomyopathy by suppression of oxidative damage and mitochondrial biogenesis impairment

86 diabetic cardiomyopathy: impact of biological sex on disease development and molecular signatures

87 cardiomyopathy classification: ongoing debate in the genomics era

88 effect of left ventricular outflow tract obstruction on left atrial mechanics in hypertrophic cardiomyopathy

89 takotsubo cardiomyopathy and dengue fever

90 mouse models in arrhythmogenic right ventricular cardiomyopathy

91 postural tachycardia syndrome and vasovagal syncope: a hidden case of obstructive cardiomyopathy without severe septal hypertrophy

92 recurrence of takotsubo cardiomyopathy

93 left atrial geometry and pump function in ischemic cardiomyopathy

94 lack of reliable clinical predictors to identify obstructive sleep apnea in patients with hypertrophic cardiomyopathy

95 pregnancy and cardiomyopathy after anthracyclines in childhood

96 characteristics of syncope in patients with dilated cardiomyopathy

97 bicuspid aortic valve with restrictive cardiomyopathy – a rare case report

98 mutation in δ-sg gene in familial dilated cardiomyopathy

99 using basic fibroblast growth factor nanoliposome combined with ultrasound-introduced technology to early intervene the diabetic cardiomyopathy

100 obstructive form of hypertrophic cardiomyopathy-left ventricular outflow tract gradient: novel methods of provocation, monitoring of biomarkers, and recent advances in the treatment

101 the correlation of pparα activity and cardiomyocyte metabolism and structure in idiopathic dilated cardiomyopathy during heart failure progression

Keyword Connections

Journals

Research Groups

Bibliographies